Gilead gets licences to three antiviral programmes from Novartis
Monday, July 22, 2019 Gilead Sciences has secured an antiviral deal with Novartis to gain exclusive global rights to preclinical
Read More
Monday, July 22, 2019 Gilead Sciences has secured an antiviral deal with Novartis to gain exclusive global rights to preclinical
Read Moreby Pharmapproc, The US pharmaceutical industry is a highly globalized industry with an enormous positive influence on global health, prosperity and
Read More22-07-2019 – Sarah Morgan designer491 / Shutterstock.com Ireland-headquartered Endo Pharmaceuticals agreed to pay $2.3 million to 18 states late last
Read MoreMonday, July 22, 2019 | DrugName : anagrelide SUDA Pharmaceuticals Ltd, a leader in oro-mucosal drug delivery, is pleased to
Read MoreFriday, June 20, 2019 Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office
Read More